Zobrazeno 1 - 10
of 251
pro vyhledávání: '"Edgardo, Cristiano"'
Publikováno v:
Arquivos de Neuro-Psiquiatria, Vol 80, Iss 07, Pp 699-705 (2022)
Background The percentage of brain volume loss (PBVL) has been classically considered as a biomarker in multiple sclerosis (MS). Objective The objective of the present study was to analyze if the PBVL during the 1st year after the onset of the diseas
Externí odkaz:
https://doaj.org/article/0b14488a9f254d0a90f0a9c0f31fc878
Autor:
Juan Ignacio ROJAS, Liliana PATRUCCO, Manuel FRUNS, Giesela HORNUNG, José FLORES, Edgar CARNERO CONTENTTI, Pablo Adrian LOPEZ, Juan Pablo PETTINICCHI, Alejandro CARIDE, Lorna GALLEGUILLOS, Jorge BARAHONA, Violeta DIAZ, Marianella HERNÁNDEZ, Ricardo ALONSO, Edgardo CRISTIANO
Publikováno v:
Arquivos de Neuro-Psiquiatria, Vol 79, Iss 4, Pp 305-309 (2021)
ABSTRACT Background: Despite the abundance of information concerning ocrelizumab in phase III clinical trials, there is scarce evidence regarding real-world patient profiles. Objective: The aim of this study was to investigate patient profiles, effec
Externí odkaz:
https://doaj.org/article/37ac32f51f7a40f8b8930a182a66a502
Autor:
Edgar Carnero Contentti, Guillermo Delgado-García, Juan Criniti, Pablo A. López, Juan Pablo Pettinicchi, Edgardo Cristiano, Jimena Miguez, Edgar Patricio Correa-Díaz, Marcelo Oswaldo Álvarez Pucha, Joselyn Elizabeth Miño Zambrano, Enrique Gómez-Figueroa, Verónica Rivas-Alonso, José Flores-Rivera, Verónica Tkachuk, Alejandro Caride, Juan Ignacio Rojas
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
BackgroundThe neutrophil-to-lymphocyte ratio (NLR) has been investigated in many autoimmune conditions as a biomarker of inflammation and/or disease activity. The role of NLR in AQP4-IgG-positive neuromyelitis optica spectrum disorders (NMOSD) is far
Externí odkaz:
https://doaj.org/article/a866ee6e826e48138208f124a9de6a49
Autor:
Edgar Carnero Contentti, Pablo A. López, Juan Pablo Pettinicchi, Verónica Tkachuk, Vanessa Daccach Marques, Ibis Soto de Castillo, Edgardo Cristiano, Liliana Patrucco, Alejandro Caride, Juan Ignacio Rojas
Publikováno v:
Neurological Sciences. 44:1731-1737
Autor:
Constanza Silvestrini Viola, Juan I. Rojas, Liliana Patrucco, Edgardo Cristiano, Jorge F. Elgart
Publikováno v:
Neurología Argentina. 15:20-27
Autor:
Juan I, Rojas, Liliana, Patrucco, Ricardo, Alonso, Pablo A, Lopez, Norma, Deri, Juan Pablo, Pettinicchi, Edgardo, Cristiano, Edgar, Carnero Contentti
Publikováno v:
Value in Health Regional Issues. 31:93-100
The objective of this study was to determine by a conjoint analysis the preferences for a range of disease-modifying treatment attributes in patients with multiple sclerosis (MS) and treating neurologists.This was a cross-sectional study throughout A
Autor:
Andrés Barboza, Jorge Correale, Ricardo Alonso, Marcos Burgos, Fernando Cáceres, Edgar Carnero-Contentti, Adriana Carrá, Edgardo Cristiano, Marcela Fiol, Orlando Garcea, Geraldine Luetic, Liliana Patrucco, Raúl Piedrabuena, Juan I. Rojas, Berenice Silva, Vladimiro Sinay, Carlos Vrech, María Célica Ysrraelit
Publikováno v:
Neurología Argentina.
Autor:
Juan Ignacio, Rojas, Liliana, Patrucco, Ricardo, Alonso, Orlando, Garcea, Norma, Deri, Edgar, Carnero Contentti, Pablo A, Lopez, Juan Pablo, Pettinicchi, Alejandro, Caride, Edgardo, Cristiano
Publikováno v:
Clinical Neuropharmacology. 45:45-51
Escalation (ES) and early high-efficacy (EHE) therapies have been the main treatment strategies adopted in multiple sclerosis (MS) in recent years. The aim of this study was to compare the effectiveness and safety of EHE versus ES strategies in MS pa
Publikováno v:
Arquivos de Neuro-Psiquiatria, Vol 74, Iss 3, Pp 235-243 (2016)
ABSTRACT Multiple sclerosis (MS) was always considered as a white matter inflammatory disease. Today, there is an important body of evidence that supports the hypothesis that gray matter involvement and the neurodegenerative mechanism are at least pa
Externí odkaz:
https://doaj.org/article/8e21faff4f2146728aef06d80e6b9e38
Autor:
Ibrahima Diouf, Charles B. Malpas, Sifat Sharmin, Izanne Roos, Dana Horakova, Eva Kubala Havrdova, Francesco Patti, Vahid Shaygannejad, Serkan Ozakbas, Guillermo Izquierdo, Sara Eichau, Marco Onofrj, Alessandra Lugaresi, Raed Alroughani, Alexandre Prat, Marc Girard, Pierre Duquette, Murat Terzi, Cavit Boz, Francois Grand'Maison, Sherif Hamdy, Patrizia Sola, Diana Ferraro, Pierre Grammond, Recai Turkoglu, Katherine Buzzard, Olga Skibina, Bassem Yamout, Ayse Altintas, Oliver Gerlach, Vincent van Pesch, Yolanda Blanco, Davide Maimone, Jeannette Lechner‐Scott, Roberto Bergamaschi, Rana Karabudak, Gerardo Iuliano, Chris McGuigan, Elisabetta Cartechini, Michael Barnett, Stella Hughes, Maria José Sa, Claudio Solaro, Ludwig Kappos, Cristina Ramo‐Tello, Edgardo Cristiano, Suzanne Hodgkinson, Daniele Spitaleri, Aysun Soysal, Thor Petersen, Mark Slee, Ernest Butler, Franco Granella, Koen de Gans, Pamela McCombe, Radek Ampapa, Bart Van Wijmeersch, Anneke van der Walt, Helmut Butzkueven, Julie Prevost, L. G. F. Sinnige, Jose Luis Sanchez‐Menoyo, Steve Vucic, Guy Laureys, Liesbeth Van Hijfte, Dheeraj Khurana, Richard Macdonell, Riadh Gouider, Tamara Castillo‐Triviño, Orla Gray, Eduardo Aguera‐Morales, Abdullah Al‐Asmi, Cameron Shaw, Norma Deri, Talal Al‐Harbi, Yara Fragoso, Tunde Csepany, Angel Perez Sempere, Irene Trevino‐Frenk, Jan Schepel, Fraser Moore, Tomas Kalincik
Publikováno v:
European Journal of Neurology, Vol. 30, no.4, p. 1014-1024 (2023)
Diouf, I, Malpas, C B, Sharmin, S, Roos, I, Horakova, D, Havrdova, E K, Patti, F, Shaygannejad, V, Ozakbas, S, Izquierdo, G, Eichau, S, Onofrj, M, Lugaresi, A, Alroughani, R, Prat, A, Girard, M, Duquette, P, Terzi, M, Boz, C, Grand'Maison, F, Hamdy, S, Sola, P, Ferraro, D, Grammond, P, Turkoglu, R, Buzzard, K, Skibina, O, Yamout, B, Altintas, A, Gerlach, O, van Pesch, V, Blanco, Y, Maimone, D, Lechner-Scott, J, Bergamaschi, R, Karabudak, R, Iuliano, G, McGuigan, C, Cartechini, E, Barnett, M, Hughes, S, Sa, M J, Solaro, C, Kappos, L, Ramo-Tello, C, Cristiano, E, Hodgkinson, S, Spitaleri, D, Soysal, A, Petersen, T, Slee, M, Butler, E, Granella, F, de Gans, K, McCombe, P, Ampapa, R, Van Wijmeersch, B, van der Walt, A, Butzkueven, H, Prevost, J, Sinnige, L G F, Sanchez-Menoyo, J L, Vucic, S, Laureys, G, Van Hijfte, L, Khurana, D, Macdonell, R, Gouider, R, Castillo-Triviño, T, Gray, O, Aguera-Morales, E, Al-Asmi, A, Shaw, C, Deri, N, Al-Harbi, T, Fragoso, Y, Csepany, T, Perez Sempere, A, Trevino-Frenk, I, Schepel, J, Moore, F & Kalincik, T 2023, ' Variability of the response to immunotherapy among subgroups of patients with multiple sclerosis ', European Journal of Neurology, vol. 30, no. 4, pp. 1014-1024 . https://doi.org/10.1111/ene.15706
EUROPEAN JOURNAL OF NEUROLOGY
Diouf, I, Malpas, C B, Sharmin, S, Roos, I, Horakova, D, Havrdova, E K, Patti, F, Shaygannejad, V, Ozakbas, S, Izquierdo, G, Eichau, S, Onofrj, M, Lugaresi, A, Alroughani, R, Prat, A, Girard, M, Duquette, P, Terzi, M, Boz, C, Grand'Maison, F, Hamdy, S, Sola, P, Ferraro, D, Grammond, P, Turkoglu, R, Buzzard, K, Skibina, O, Yamout, B, Altintas, A, Gerlach, O, van Pesch, V, Blanco, Y, Maimone, D, Lechner-Scott, J, Bergamaschi, R, Karabudak, R, Iuliano, G, McGuigan, C, Cartechini, E, Barnett, M, Hughes, S, Sa, M J, Solaro, C, Kappos, L, Ramo-Tello, C, Cristiano, E, Hodgkinson, S, Spitaleri, D, Soysal, A, Petersen, T, Slee, M, Butler, E, Granella, F, de Gans, K, McCombe, P, Ampapa, R, Van Wijmeersch, B, van der Walt, A, Butzkueven, H, Prevost, J, Sinnige, L G F, Sanchez-Menoyo, J L, Vucic, S, Laureys, G, Van Hijfte, L, Khurana, D, Macdonell, R, Gouider, R, Castillo-Triviño, T, Gray, O, Aguera-Morales, E, Al-Asmi, A, Shaw, C, Deri, N, Al-Harbi, T, Fragoso, Y, Csepany, T, Perez Sempere, A, Trevino-Frenk, I, Schepel, J, Moore, F & Kalincik, T 2023, ' Variability of the response to immunotherapy among subgroups of patients with multiple sclerosis ', European Journal of Neurology, vol. 30, no. 4, pp. 1014-1024 . https://doi.org/10.1111/ene.15706
EUROPEAN JOURNAL OF NEUROLOGY
Background and purpose: This study assessed the effect of patient characteristics on the response to disease-modifying therapy (DMT) in multiple sclerosis (MS).Methods: We extracted data from 61,810 patients from 135 centers across 35 countries from
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::671ece9270fb2e852a3dff85178ccb02
https://hdl.handle.net/2078.1/276383
https://hdl.handle.net/2078.1/276383